Rankings
▼
Calendar
JAZZ FY 2011 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$11B
FY 2011 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$272M
+56.7% YoY
Gross Profit
$258M
94.9% margin
Operating Income
$128M
46.9% margin
Net Income
$125M
45.9% margin
EPS (Diluted)
$2.67
Cash Flow
Operating Cash Flow
$152M
Free Cash Flow
$146M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$254M
Total Liabilities
$61M
Stockholders' Equity
$193M
Cash & Equivalents
$82M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$272M
$174M
+56.7%
Gross Profit
$258M
$160M
+61.2%
Operating Income
$128M
$58M
+121.2%
Net Income
$125M
$33M
+281.3%
← FY 2010
All Quarters
FY 2012 →